Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2010

01.08.2010 | Retinal Disorders

Long-term outcomes of Oxane Hd as intraocular tamponade in the treatment of complicated retinal detachment

verfasst von: Qianli Meng, Shaochong Zhang, He Cheng, Xuan Chen, Yixuan Jin

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

To evaluate the efficacy and safety of heavy silicone oil Oxane Hd as intraocular tamponade in the treatment of complicated retinal detachment (RD).

Methods

Forty eyes of 40 patients with complicated RD were recruited for this prospective study. Inclusion criteria were proliferative vitreoretinopathy grade ≥ CP2, mainly inferior and posterior retinal breaks, or superior retinal breaks with patient’s inability to posture. Oxane Hd was used as intraocular tamponade. The retinal status, the best-corrected visual acuity (BCVA) results, and any complications were observed.

Results

The mean duration of Oxane Hd endotamponade was 87.9 ± 10.4 days, and the mean follow-up time after Oxane Hd removal was 438.1 ± 153.7 days. The primary anatomical success rate after Oxane Hd removal was 87.5%, and with further intervention 97.5%. The BCVA significantly improved, from mean logMAR 2.12 ± 0.60 to 1.38 ± 0.59 (P < 0.001). The postoperative complications included temporary inflammatory reaction, moderately high intraocular pressure, heavy silicone oil emulsification, lens opacity and retinal proliferative membranes.

Conclusions

Without a requirement for postoperative prone position, heavy silicone oil Oxane Hd is effective and safe for the treatment of complicated RD with inferior and posterior breaks. Larger groups and a longer follow-up period will be included to further evaluate the efficacy with Oxane Hd in superior retinal breaks.
Literatur
1.
Zurück zum Zitat Abrams GW, Azen SP, McCuen BW 2nd, Flynn HW Jr, Lai MY, Ryan SJ (1997) Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone study report 11. Arch Ophthalmol 115:335–344PubMed Abrams GW, Azen SP, McCuen BW 2nd, Flynn HW Jr, Lai MY, Ryan SJ (1997) Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone study report 11. Arch Ophthalmol 115:335–344PubMed
2.
Zurück zum Zitat Azen SP, Scott IU, Flynn HW Jr, Lai MY, Topping TM, Benati L, Trask DK, Rogus LA (1998) Silicone oil in the repair of complex retinal detachments. A prospective observation multicenter study. Ophthalmology 105:1587–1597CrossRefPubMed Azen SP, Scott IU, Flynn HW Jr, Lai MY, Topping TM, Benati L, Trask DK, Rogus LA (1998) Silicone oil in the repair of complex retinal detachments. A prospective observation multicenter study. Ophthalmology 105:1587–1597CrossRefPubMed
3.
Zurück zum Zitat Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17–24CrossRefPubMed Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17–24CrossRefPubMed
4.
Zurück zum Zitat Meinert H, Roy T (2000) Semifluorinated alkanes—a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10:189–197PubMed Meinert H, Roy T (2000) Semifluorinated alkanes—a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10:189–197PubMed
5.
Zurück zum Zitat Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF (2002) Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133:95–101CrossRefPubMed Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF (2002) Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133:95–101CrossRefPubMed
6.
Zurück zum Zitat Wolf S, Schön V, Meier P, Wiedemann P (2003) Silicone oil–RMN3 micture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23:335–342CrossRefPubMed Wolf S, Schön V, Meier P, Wiedemann P (2003) Silicone oil–RMN3 micture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23:335–342CrossRefPubMed
7.
Zurück zum Zitat Rizzo S, Genovesi-Ebert F, Belting C, Vento A, Cresti F (2005) A pilot study on the use of silicone oil–RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol 243:1153–1157CrossRefPubMed Rizzo S, Genovesi-Ebert F, Belting C, Vento A, Cresti F (2005) A pilot study on the use of silicone oil–RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol 243:1153–1157CrossRefPubMed
8.
Zurück zum Zitat Berker N, Batman C, Ozdamar Y, Eranil S, Aslan O, Zilelioglu O (2007) Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment. Eur J Ophthalmol 17:797–803PubMed Berker N, Batman C, Ozdamar Y, Eranil S, Aslan O, Zilelioglu O (2007) Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment. Eur J Ophthalmol 17:797–803PubMed
9.
Zurück zum Zitat Boscia F, Furino C, Recchimurzo N, Besozzi G, Sborgia G, Sborgia C (2008) Oxane HD vs silicone oil and scleral buckle in retinal detachment with proliferative vitreoretinopathy and inferior retinal breaks. Graefes Arch Clin Exp Ophthalmol 246:943–948CrossRefPubMed Boscia F, Furino C, Recchimurzo N, Besozzi G, Sborgia G, Sborgia C (2008) Oxane HD vs silicone oil and scleral buckle in retinal detachment with proliferative vitreoretinopathy and inferior retinal breaks. Graefes Arch Clin Exp Ophthalmol 246:943–948CrossRefPubMed
10.
Zurück zum Zitat Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159–165PubMed Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159–165PubMed
11.
Zurück zum Zitat Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388–391PubMed Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388–391PubMed
12.
Zurück zum Zitat Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN, Manousakis E, Herbert EN (2005) A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 89:662–665CrossRefPubMed Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN, Manousakis E, Herbert EN (2005) A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 89:662–665CrossRefPubMed
13.
Zurück zum Zitat Sandner D, Engelmann K (2006) First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 244:609–619CrossRefPubMed Sandner D, Engelmann K (2006) First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 244:609–619CrossRefPubMed
14.
Zurück zum Zitat Rizzo S, Belting C, Genovesi-Ebert F, Cresti F, Vento A, Martini R (2006) Successful treatment of persistent macular holes using “heavy silicone oil” as intraocular tamponade. Retina 26:905–908CrossRefPubMed Rizzo S, Belting C, Genovesi-Ebert F, Cresti F, Vento A, Martini R (2006) Successful treatment of persistent macular holes using “heavy silicone oil” as intraocular tamponade. Retina 26:905–908CrossRefPubMed
15.
Zurück zum Zitat Sandner D, Herbrig E, Engelmann K (2007) High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol 245:1097–1105CrossRefPubMed Sandner D, Herbrig E, Engelmann K (2007) High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol 245:1097–1105CrossRefPubMed
16.
Zurück zum Zitat Herbrig E, Sandner D, Engelmann K (2007) Anatomical and functional results of endotamponade with heavy silicone oil—Densiron 68—in complicated retinal detachment. Ophthalmic Res 39:198–206CrossRefPubMed Herbrig E, Sandner D, Engelmann K (2007) Anatomical and functional results of endotamponade with heavy silicone oil—Densiron 68—in complicated retinal detachment. Ophthalmic Res 39:198–206CrossRefPubMed
17.
Zurück zum Zitat Auriol S, Pagot-Mathis V, Mahieu L, Lemoine C, Mathis A (2008) Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol 246:1383–1389CrossRefPubMed Auriol S, Pagot-Mathis V, Mahieu L, Lemoine C, Mathis A (2008) Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol 246:1383–1389CrossRefPubMed
18.
Zurück zum Zitat Romano MR, Stappler T, Marticorena J, Groenewald C, Pearce I, Gibran SK, Wong D, Heimann H (2008) Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 246:1541–1546CrossRefPubMed Romano MR, Stappler T, Marticorena J, Groenewald C, Pearce I, Gibran SK, Wong D, Heimann H (2008) Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 246:1541–1546CrossRefPubMed
19.
Zurück zum Zitat Li W, Zheng J, Zheng Q, Wu R, Wang X, Xu M (2009) Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye, doi:10.1038/eye.2009.57 Li W, Zheng J, Zheng Q, Wu R, Wang X, Xu M (2009) Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye, doi:10.​1038/​eye.​2009.​57
21.
Zurück zum Zitat Schurmans A, Van Calster J, Stalmans P (2009) Macular hole surgery with inner limiting membrane peeling, endodrainage, and heavy silicone oil tamponade. Am J Ophthalmol 147:495–500CrossRefPubMed Schurmans A, Van Calster J, Stalmans P (2009) Macular hole surgery with inner limiting membrane peeling, endodrainage, and heavy silicone oil tamponade. Am J Ophthalmol 147:495–500CrossRefPubMed
22.
Zurück zum Zitat Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes. Graefes Arch Clin Exp Ophthalmol 247:1471–1476CrossRefPubMed Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes. Graefes Arch Clin Exp Ophthalmol 247:1471–1476CrossRefPubMed
23.
Zurück zum Zitat Tseng JJ, Barile GR, Schiff WM, Akar Y, Vidne-Hay O, Chang S (2005) Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy. Am J Ophthalmol 140:628–636PubMed Tseng JJ, Barile GR, Schiff WM, Akar Y, Vidne-Hay O, Chang S (2005) Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy. Am J Ophthalmol 140:628–636PubMed
24.
Zurück zum Zitat Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD (2006) Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 113:2041–2047CrossRefPubMed Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD (2006) Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 113:2041–2047CrossRefPubMed
25.
Zurück zum Zitat Schiff WM, Hwang JC, Ober MD, Olson JL, Dhrami-Gavazi E, Barile GR, Chang S, Mandava N (2007) Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol 125:1161–1167CrossRefPubMed Schiff WM, Hwang JC, Ober MD, Olson JL, Dhrami-Gavazi E, Barile GR, Chang S, Mandava N (2007) Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol 125:1161–1167CrossRefPubMed
26.
Zurück zum Zitat Tomlins PJ, Woodcock MG, Spencer N, Kirkby GR (2007) Nuclear magnetic resonance analysis of emulsified silicone oil RMN-3 (Oxane HD). Br J Ophthalmol 91:1379–1381CrossRefPubMed Tomlins PJ, Woodcock MG, Spencer N, Kirkby GR (2007) Nuclear magnetic resonance analysis of emulsified silicone oil RMN-3 (Oxane HD). Br J Ophthalmol 91:1379–1381CrossRefPubMed
27.
Zurück zum Zitat Lai WW, Wong D, Li KK, Leow PL (2008) Emulsification and inverted hypopyon formation of Oxane HD in the anterior chamber. Graefes Arch Clin Exp Ophthalmol 246:1633–1635CrossRefPubMed Lai WW, Wong D, Li KK, Leow PL (2008) Emulsification and inverted hypopyon formation of Oxane HD in the anterior chamber. Graefes Arch Clin Exp Ophthalmol 246:1633–1635CrossRefPubMed
Metadaten
Titel
Long-term outcomes of Oxane Hd as intraocular tamponade in the treatment of complicated retinal detachment
verfasst von
Qianli Meng
Shaochong Zhang
He Cheng
Xuan Chen
Yixuan Jin
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 8/2010
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1351-8

Weitere Artikel der Ausgabe 8/2010

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2010 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.